Despite the substantial global burden of human fungal infections, there are no approved
fungal vaccines to protect at risk individuals. Here, we review the progress that has been …

Vaccines have always been the most effective preventive treatment. Advancements in the
field of vaccine is inseparable from adjuvants. Adjuvants are substances added to vaccines …

Vaccination with glucan particles (GP) containing the Cryptococcus neoformans chitin
deacetylases Cda1 and Cda2 protect mice against experimental cryptococcosis. Here …

Research over the past several decades has provided insight into the mode of action of
adjuvants. However, the main focus of attention has been the efficacy in the induction of …

Objectives: Dermatophytosis is a group of cutaneous diseases widely distributed in human
and animals. It causes serious infection in some human cases and economic losses in farm …

The prevalence of fungal infections is increasing worldwide, especially that of aspergillosis,
which previously only affected people with immunosuppression. Aspergillus fumigatus can …

Local reactions are the most frequent adverse event associated with vaccines. Adjuvants are
major constituents of many vaccines and they are frequently involved in these reactions …

Fungal infections are emerging as a major problem in part due to high mortality associated
with systemic infections, especially in the case of immunocompromised patients. With the …

In recent years, fungal vaccine research emanated significant findings in the field of
antifungal T-cell immunity. The generation of effector T cells is essential to combat many …

Sporotrichosis is a subcutaneous mycosis caused by several closely related thermo-
dimorphic fungi of the Sporothrix schenckii species complex, affecting humans and other …